WallStSmart

Salesforce.com Inc (CRM)vsDocebo Inc (DCBO)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Salesforce.com Inc generates 17011% more annual revenue ($41.52B vs $242.69M). CRM leads profitability with a 18.0% profit margin vs 15.5%. DCBO trades at a lower P/E of 15.1x. CRM earns a higher WallStSmart Score of 63/100 (C+).

CRM

Buy

63

out of 100

Grade: C+

Growth: 6.7Profit: 7.0Value: 10.0Quality: 6.0
Piotroski: 5/9Altman Z: 1.83

DCBO

Buy

58

out of 100

Grade: C

Growth: 8.7Profit: 8.5Value: 8.3Quality: 5.0
Piotroski: 3/9Altman Z: 0.65
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CRMUndervalued (+34.2%)

Margin of Safety

+34.2%

Fair Value

$276.43

Current Price

$181.96

$94.47 discount

UndervaluedFair: $276.43Overvalued
DCBOUndervalued (+68.5%)

Margin of Safety

+68.5%

Fair Value

$59.90

Current Price

$18.54

$41.36 discount

UndervaluedFair: $59.90Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CRM4 strengths · Avg: 8.5/10
Market CapQuality
$171.49B9/10

Large-cap with strong market position

Debt/EquityHealth
0.199/10

Conservative balance sheet, low leverage

Price/BookValuation
2.9x8/10

Reasonable price relative to book value

Free Cash FlowQuality
$5.32B8/10

Generating 5.3B in free cash flow

DCBO4 strengths · Avg: 9.5/10
Return on EquityProfitability
56.9%10/10

Every $100 of equity generates 57 in profit

EPS GrowthGrowth
141.7%10/10

Earnings expanding 141.7% YoY

Debt/EquityHealth
0.0610/10

Conservative balance sheet, low leverage

P/E RatioValuation
15.1x8/10

Attractively priced relative to earnings

Areas to Watch

CRM1 concerns · Avg: 4.0/10
Altman Z-ScoreHealth
1.834/10

Grey zone — moderate risk

DCBO3 concerns · Avg: 2.7/10
Market CapQuality
$557.21M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Altman Z-ScoreHealth
0.652/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : CRM

The strongest argument for CRM centers on Market Cap, Debt/Equity, Price/Book. Profitability is solid with margins at 18.0% and operating margin at 19.2%. Revenue growth of 12.1% demonstrates continued momentum.

Bull Case : DCBO

The strongest argument for DCBO centers on Return on Equity, EPS Growth, Debt/Equity. Profitability is solid with margins at 15.5% and operating margin at 15.4%. Revenue growth of 10.5% demonstrates continued momentum.

Bear Case : CRM

The primary concerns for CRM are Altman Z-Score.

Bear Case : DCBO

The primary concerns for DCBO are Market Cap, Piotroski F-Score, Altman Z-Score.

Key Dynamics to Monitor

CRM carries more volatility with a beta of 1.31 — expect wider price swings.

CRM is growing revenue faster at 12.1% — sustainability is the question.

CRM generates stronger free cash flow (5.3B), providing more financial flexibility.

Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CRM scores higher overall (63/100 vs 58/100), backed by strong 18.0% margins and 12.1% revenue growth. DCBO offers better value entry with a 68.5% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Salesforce.com Inc

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Salesforce.com, Inc. is an American cloud-based software company headquartered in San Francisco, California. It provides customer relationship management (CRM) service and also provides a complementary suite of enterprise applications focused on customer service, marketing automation, analytics, and application development.

Visit Website →

Docebo Inc

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Docebo Inc. provides a cloud-based learning management system to train internal and external workforce, partners, and customers in North America, Europe, and the Asia-Pacific region. The company is headquartered in Toronto, Canada.

Visit Website →

Want to dig deeper into these stocks?